• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The effect of experience of illness on health state valuations.

作者信息

Dolan P

机构信息

Department of Economics, University of Newcastle-Upon-Tyne, England.

出版信息

J Clin Epidemiol. 1996 May;49(5):551-64. doi: 10.1016/0895-4356(95)00532-3.

DOI:10.1016/0895-4356(95)00532-3
PMID:8636729
Abstract

There is increasing interest in health status measurement and the relative weights that patients and the general public attach to different states of health and illness. One important question that has been raised is whether preferences differ according to the characteristics of the respondents, such as their experience of illness. The results presented in this article suggest that current health status has an important effect on the valuations attached to different health states, with those in poorer health generally giving higher valuations. Past experience of illness, on the other hand, appears to have a negligible effect on valuations. These findings pose real problems for policy makers. To the problem of whose values should count can be added the problem of when these values should count, since the results imply that different valuations may be given by the same respondent depending on how recent their experience of illness was.

摘要

相似文献

1
The effect of experience of illness on health state valuations.
J Clin Epidemiol. 1996 May;49(5):551-64. doi: 10.1016/0895-4356(95)00532-3.
2
The effect of past and present illness experience on the valuations of health states.过去和现在的疾病经历对健康状态估值的影响。
Med Care. 1995 Apr;33(4 Suppl):AS255-63.
3
Valuations of EQ-5D health states: are the United States and United Kingdom different?EQ-5D健康状态的估值:美国和英国有所不同吗?
Med Care. 2005 Mar;43(3):221-8. doi: 10.1097/00005650-200503000-00004.
4
Economic evaluation in schistosomiasis: valuation of health states preferences. A research note.血吸虫病的经济评估:健康状态偏好的估值。一项研究报告。
Health Econ. 1998 Sep;7(6):551-6. doi: 10.1002/(sici)1099-1050(199809)7:6<551::aid-hec367>3.0.co;2-7.
5
Valuing health status using VAS and TTO: what lies behind the numbers?使用视觉模拟评分法(VAS)和时间权衡法(TTO)评估健康状况:数字背后隐藏着什么?
Soc Sci Med. 1997 Oct;45(8):1289-97. doi: 10.1016/s0277-9536(97)00057-9.
6
Productivity costs in health-state valuations : does explicit instruction matter?健康状态评估中的生产力成本:明确的指导重要吗?
Pharmacoeconomics. 2006;24(4):401-14. doi: 10.2165/00019053-200624040-00009.
7
Inconsistency and health state valuations.不一致性与健康状态评估。
Soc Sci Med. 1996 Feb;42(4):609-15. doi: 10.1016/0277-9536(95)00161-1.
8
EuroQol: health-related quality of life measurement. Valuations of health states by the general public in Norway.欧洲五维度健康量表:与健康相关的生活质量测量。挪威普通公众对健康状态的估值。
Health Policy. 1991 Jun;18(1):25-36. doi: 10.1016/0168-8510(91)90141-j.
9
The valuation of states of ill-health: the impact of age and disability.
Age Ageing. 1991 Jan;20(1):37-40. doi: 10.1093/ageing/20.1.37.
10
Modelling valuations for health states: the effect of duration.健康状态估值建模:持续时间的影响。
Health Policy. 1996 Dec;38(3):189-203. doi: 10.1016/0168-8510(96)00853-6.

引用本文的文献

1
Conceptual Framework for Optimised Proxy Value Set Selection Through Supra-National Value Set Development for the EQ-5D Instruments.通过超国家 EQ-5D 工具值集开发优化代理值集选择的概念框架。
Pharmacoeconomics. 2022 Dec;40(12):1221-1234. doi: 10.1007/s40273-022-01194-y. Epub 2022 Oct 6.
2
A systematic literature review of disability weights measurement studies: evolution of methodological choices.残疾权重测量研究的系统文献综述:方法选择的演变
Arch Public Health. 2022 Mar 24;80(1):91. doi: 10.1186/s13690-022-00860-z.
3
Estimating an EQ-5D-3L Value Set for Romania Using Time Trade-Off.
使用时间权衡法估算罗马尼亚的 EQ-5D-3L 值集。
Int J Environ Res Public Health. 2021 Jul 11;18(14):7415. doi: 10.3390/ijerph18147415.
4
Assessing the reliability and validity of the ICECAP-A instrument in Chinese type 2 diabetes patients.评估ICECAP-A工具在中国2型糖尿病患者中的信度和效度。
Health Qual Life Outcomes. 2021 Jan 6;19(1):5. doi: 10.1186/s12955-020-01632-5.
5
The minimally important difference of the Gastrointestinal Quality of Life Index for symptomatic gallstone surgery.症状性胆石病手术的胃肠道生活质量指数的最小重要差异。
Surg Endosc. 2021 Dec;35(12):6938-6948. doi: 10.1007/s00464-020-08205-z. Epub 2021 Jan 4.
6
Patients' Self-Reported Disability Weights of Top-Ranking Diseases in Thailand: Do They Differ by Socio-Demographic and Illness Characteristics?泰国排名前几位疾病的患者自评残疾权重:它们是否因社会人口学和疾病特征而有所不同?
Int J Environ Res Public Health. 2020 Mar 2;17(5):1595. doi: 10.3390/ijerph17051595.
7
Cultural Values: Can They Explain Differences in Health Utilities between Countries?文化价值观:它们能否解释国家间健康效用的差异?
Med Decis Making. 2019 Jul;39(5):605-616. doi: 10.1177/0272989X19841587. Epub 2019 Jul 1.
8
Patient and Public Preferences for Treatment Attributes in Parkinson's Disease.帕金森病治疗属性的患者和公众偏好。
Patient. 2017 Dec;10(6):763-772. doi: 10.1007/s40271-017-0247-7.
9
Mapping EQ-5D utilities to GBD 2010 and GBD 2013 disability weights: results of two pilot studies in Belgium.将EQ-5D效用值映射到全球疾病负担研究2010版和2013版残疾权重:比利时两项试点研究的结果
Arch Public Health. 2017 Feb 6;75:6. doi: 10.1186/s13690-017-0174-z. eCollection 2017.
10
Dutch guidelines for economic evaluation: 'from good to better' in theory but further away from pharmaceuticals in practice?荷兰经济评估指南:理论上“从好到更好”,但在实践中与药品的距离却更远了?
J R Soc Med. 2017 Mar;110(3):98-103. doi: 10.1177/0141076817690395. Epub 2017 Jan 24.